Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Evolution of antibody immunity to SARS-CoV-2

(2021) Christian Gaebler et al.   NATURE

Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients

(2021) Jean-Rémi Lavillegrand et al.   Annals of Intensive Care

Attributes and predictors of long COVID

(2021) Carole H. Sudre et al.   NATURE MEDICINE

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

(2021)   NEW ENGLAND JOURNAL OF MEDICINE

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

(2021) Ryan S Thwaites et al.   Science Immunology

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

(2021) Obbina Abani et al.   LANCET

High-dimensional characterization of post-acute sequelae of COVID-19

(2021) Ziyad Al-Aly et al.   NATURE

Post-acute COVID-19 syndrome

(2021) Ani Nalbandian et al.   NATURE MEDICINE

Persistent symptoms and association with inflammatory cytokine signatures in recovered COVID-19 patients

(2021) Sean Wei Xiang Ong et al.   Open Forum Infectious Diseases

Immunological and inflammatory profiles during acute and convalescent phases of severe/ critically ill COVID-19 patients

(2021) Qigao Chen et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Long COVID in a prospective cohort of home-isolated patients

(2021) Bjørn Blomberg et al.   NATURE MEDICINE

New-onset IgG autoantibodies in hospitalized patients with COVID-19

(2021) Sarah Esther Chang et al.   Nature Communications

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

(2021) Michael J. Peluso et al.   Science Advances

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

(2020) Juanjuan Zhao et al.   CLINICAL INFECTIOUS DISEASES

Subacute Thyroiditis After Sars-COV-2 Infection

(2020) Alessandro Brancatella et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Longitudinal analyses reveal immunological misfiring in severe COVID-19

(2020) Carolina Lucas et al.   NATURE

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

(2020) Quan-Xin Long et al.   NATURE MEDICINE

New-Onset Diabetes in Covid-19

(2020) Francesco Rubino et al.   NEW ENGLAND JOURNAL OF MEDICINE

IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study

(2020) José María Galván-Román et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

An inflammatory cytokine signature predicts COVID-19 severity and survival

(2020) Diane Marie Del Valle et al.   NATURE MEDICINE

A dynamic COVID-19 immune signature includes associations with poor prognosis

(2020) Adam G. Laing et al.   NATURE MEDICINE

Humoral Immune Response to SARS-CoV-2 in Iceland

(2020) Daniel F. Gudbjartsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

(2020) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019

(2020) Ekasit Kowitdamrong et al.   PLoS One

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

(2020) Olivier Hermine et al.   JAMA Internal Medicine

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

(2020) Carlo Salvarani et al.   JAMA Internal Medicine

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

(2020) Jeffrey Seow et al.   Nature Microbiology

Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production

(2020) Yuezhou Chen et al.   CELL

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

(2020) Carlos Salama et al.   NEW ENGLAND JOURNAL OF MEDICINE

C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19

(2020) Milad Sharifpour et al.   PLoS One

Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma

(2020) Tania S Bonny et al.   Open Forum Infectious Diseases

IL-6 as a keystone cytokine in health and disease

(2015) Christopher A Hunter et al.   NATURE IMMUNOLOGY

Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18

(2015) Stamatis Papathanasiou et al.   NATURE MEDICINE

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

(2015) George D. Kalliolias et al.   Nature Reviews Rheumatology

Soluble Markers of Inflammation and Coagulation but Not T-Cell Activation Predict Non–AIDS-Defining Morbid Events During Suppressive Antiretroviral Treatment

(2014) Allan R. Tenorio et al.   JOURNAL OF INFECTIOUS DISEASES

Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection

(2014) Peter W. Hunt et al.   JOURNAL OF INFECTIOUS DISEASES

HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality

(2014) Sergio Serrano-Villar et al.   PLoS Pathogens

Interleukin-6 Overexpression Induces Pulmonary Hypertension

(2008) M. Kathryn Steiner et al.   CIRCULATION RESEARCH